Biogen Q2 Revenue and Adjusted EPS Beat Expectations, Guidance Raised

AAPL +0.22% SOFI -1.01% QCOM +0.13% BMY +1.33% NCLH +4.30% 21 more

1. 1Biogen (BIIB) reported Q2 revenue of $2.74 billion, exceeding the Bloomberg consensus of $2.47 billion
2. 2Adjusted EPS came in at $3.60, beating the $2.89 estimate, while growth portfolio revenue rose 24% to $1.06 billion
3. 3The company raised its full-year underlying non-GAAP diluted EPS guidance to $15.85–$16.85 and forecast mid-single-digit revenue growth for the year

Source InvestorsHub +13 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →